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Cys2His2 zinc-ﬁngers (C2H2 ZFs) mediate a wide variety of protein–DNA and protein–protein
interactions. DNA-binding C2H2 ZFs can be shufﬂed to yield artiﬁcial proteins with different DNA-
binding speciﬁcities. Here we demonstrate that shufﬂing of C2H2 ZFs from transcription factor
dimerization zinc-ﬁnger (DZF) domains can also yield two-ﬁnger DZFs with novel protein–protein
interaction speciﬁcities. We show that these synthetic protein–protein interaction domains can be
used to mediate activation of a single-copy reporter gene in bacterial cells and of an endogenous
gene in human cells. In addition, the synthetic two-ﬁnger domains we constructed can also be
linked together to create more extended, four-ﬁnger interfaces. Our results demonstrate that
shufﬂing of C2H2 ZFs can yield artiﬁcial protein-interaction components that should be useful for
applications in synthetic biology.
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Introduction
Construction of complex synthetic cellular networks will
require access to large sets of macromolecular components
such as DNA-binding proteins and protein interaction
domains. Cys2His2 zinc-ﬁngers (C2H2 ZFs) provide an
important framework for the design of synthetic proteins with
novel interaction speciﬁcities. C2H2 ZFs are compact mole-
cular recognition domains found in 2–3% of all human genes
(Landeretal,2001; Tupleretal,2001; Venteretal,2001; Muller
et al, 2002). These domains consist of a short b-sheet and an
a-helix (whose overall fold is stabilized by coordination of
a zinc atom by conserved cysteines and histidines) and are
typicallyfoundinproteinsastandemarrays.C2H2ZFsmediate
speciﬁc recognition of different DNA (Wolfe et al, 2000), RNA
(Lu et al, 2003), and protein sequences (Mackay and Crossley,
1998). The functional versatilityand widespreadprevalence of
these domains demonstrate that evolution has extensively
utilized the C2H2 ZF fold to mediate interactions with a
variety of different macromolecules.
A number of studies have shown that naturally occurring
and engineered DNA-binding C2H2 ZFs can be ‘mixed and
matched’ to create synthetic multiﬁnger arrays possessing
novel DNA-binding speciﬁcities (Klug, 1999; Pabo et al, 2001;
Falke and Juliano, 2003; Jamieson et al, 2003; Lee et al, 2003;
Blancafort et al, 2004; Jantz et al, 2004). These synthetic DNA-
binding domains (DBDs) can be fused to transcriptional
regulatory domains to create artiﬁcial transcription factors
capable of altering expression of speciﬁc endogenous genes in
cell types ranging from yeast to human as well as in whole
organisms (Klug, 1999; Pabo et al, 2001; Falke and Juliano,
2003; Jamieson et al, 2003; Lee et al, 2003; Blancafort et al,
2004; Jantz et al, 2004). In addition, recent work has
demonstrated that artiﬁcial C2H2 ZFs can be used to construct
synthetic two-dimensional gene networks that produce
differentpatterns ofgene expressioninacell-freeenvironment
(Isalan et al, 2005). Engineered C2H2 ZFs will undoubtedly
play a central role in synthetic biology efforts and therefore
improving our capabilities to engineer the interaction speciﬁ-
cities of these domains is an important goal for future studies.
However, in contrast to our current detailed understanding
of DNA-binding C2H2 ZFs, relatively little is understood at
a physical–chemical level about protein-interacting C2H2 ZFs
(Mackay and Crossley, 1998; McCarty et al, 2003; Westman
et al, 2004). Our limited understanding of protein-interacting
DZFs also contrasts with more detailed knowledge about
dimerization and multimerization by leucine zippers, a widely
distributed family of motifs found in eukaryotic transcription
factors (Newman and Keating, 2003). Leucine zippers can
interact as parallel or antiparallel coiled-coils, can mediate
homo- and/or hetero-typic interactions, and can interact as
dimers,trimers,orhigherorderoligomers(Vinsonetal,2002).
These detailed insights have come from studies of naturally
occurring motifs (O’Shea et al, 1989; O’Shea et al, 1991) but
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engineered artiﬁcial leucine zippers with novel interaction
speciﬁcities, geometries, and oligomerization states (Hu et al,
1990; Harbury et al, 1993; Hu et al, 1993; O’Shea et al, 1993;
Vinson et al, 1993; Harbury et al, 1994; Zeng et al, 1997; Moll
et al, 2001).
We wished to determine whether protein-interacting C2H2
ZFs might be shufﬂed to engineer a repertoire of ﬁnger arrays
with novel protein–protein interaction speciﬁcities. We chose
tofocusour initialeffortsonC2H2ZFsfromdimerizationzinc-
ﬁnger (DZF) domains found in various transcription factors
including members of the mammalian Ikaros family of
transcription factors, the Drosophila melanogaster Hunchback
protein, and thehuman TRPS-1 protein (Hahm et al, 1994; Sun
et al, 1996; Morgan et al, 1997; Hahm et al, 1998; Perdomo
et al, 2000; McCarty et al, 2003; Westman et al, 2003). DZFs
consist of two C2H2 ZFs joined bya short linker (Figure 1) and
aresufﬁcientformediatinghomo-andheterotypicinteractions
among these various transcription factors. Previous studies
have shown that both C2H2 ZFs in a DZF are required for
efﬁcient interaction, suggesting that both ﬁngers contribute
binding energy (Sun et al, 1996; McCarty et al, 2003; Westman
et al, 2004). We were particularly interested in focusing on
DZFs because a recent report described a functional hybrid
DZF constructed from portions of the human Ikaros and
Drosophila Hunchback DZFs, a result which strongly sug-
gested that shufﬂing of DZF-derived C2H2 ZF domains might
yield synthetic DZFs with novel protein–protein interaction
speciﬁcities (McCarty et al, 2003).
An additional motivation for our studies was to gain greater
insight into the interaction geometry of DZF-mediated inter-
actions. The single synthetic hybrid Ikaros–Hunchback DZF
described above exhibited a novel homotypic interaction
speciﬁcity, which suggested that this DZF interacted in a
‘parallel’ interaction mode with each of its C2H2 ZFs
interacting with its counterpart in the opposing monomer
(McCarty et al, 2003). We reasoned that creation of more
synthetic DZFs by domain shufﬂing would provide an
additional test of the idea that DZFs interact in a parallel
manner.
In this report, we demonstrate that shufﬂing protein-
interacting C2H2 ZFs from DZF domains can yield ﬁnger
arrays with novel protein–protein interaction speciﬁcities and
that these DZFs can be used to build synthetic transcription
factors capable of altering gene expression in human and
bacterial cells. To do this, we created libraries of two-ﬁnger
units by shufﬂing C2H2 ZFs from DZFs found in transcription
factors ranging from D. melanogaster to humans and then
identiﬁed pairs of interacting two-ﬁnger domains using a
bacterialtwo-hybrid(B2H)system(Doveet al,1997; Doveand
Hochschild, 1998; Joung et al, 2000). We show that the
synthetic two-ﬁnger DZFs we identiﬁed can be used to
construct a series of artiﬁcial transcriptional activators in
Escherichia coli or to construct artiﬁcial transcriptional
activators of the endogenous VEGF-A gene in human cells
(by-passing normal physiologic mechanisms for regulating
this gene). In addition, we show that our synthetic two-ﬁnger
domains can be linked together to create more extended four-
ﬁnger protein–protein interaction interfaces. Surprisingly,
analysis of the interaction speciﬁcities of our synthetic
domains suggests that DZFs can also interact in an antiparallel
mode in addition to the parallel mode described previously
(McCarty et al, 2003). Our ﬁndings have implications for
understandingnaturallyoccurringC2H2ZF-mediatedprotein–
protein interactions and expand the number and kind of
protein–protein interaction ‘parts’ potentially available
to synthetic biologists for building or modifying cellular
networks.
Results
Detecting and identifying DZF–DZF interactions
using a B2H system
We reasoned that we could create libraries of synthetic DZFs
with potentially altered interaction speciﬁcities by shufﬂing
Figure1 DZFdomainsfromvarioustranscriptionfactors.ThetopoftheﬁgurepresentsaschematicofaDZFdomainwithamino-(N)andcarboxy-(C)terminalﬁngers
represented as ovals and the interﬁnger linker as a connecting bar. The bottom portion of the ﬁgure shows an amino-acid sequence alignment of DZFs from human
Ikaros, human Helios, human Aiolos, human Eos, human Pegasus, human TRPS-1, Drosophila melanogaster (D.m.) Hunchback, Locusta migratoria (L.m.)
Hunchback, Helobdella triserialis (H.t.) Hunchback, and Caenorhabditis elegans (C.e.) Hunchback. Conserved cysteines and histidines are highlighted in blue.
Positions showing 80% or greater conservation among the 10 DZF domains shown are highlighted in yellow.
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that interacting pairs of synthetic DZFs from these shufﬂed
libraries could be identiﬁed using a B2H selection system
designed to detect protein–protein interactions (Joung, 2001;
Dove and Hochschild, 2004). Therefore, we ﬁrst sought to
determine whether the B2H system could be used to detect
interactions between DZF domains.
The B2H system is based on the observation that in an
appropriately engineered E. coli strain, the interaction of two
arbitrary protein domains (X and Y) can trigger transcriptional
activation of a linked reporter gene(s) (e.g., the lacZ gene
encoding b-galactosidase or a selectable marker gene; Dove
et al, 1997; Dove and Hochschild, 1998; Figure 2A). This
activation occurs when a hybrid protein consisting of a DBD
(e.g., the DBD of the Zif268 transcription factor) fused to
protein domain X binds upstream of a weak test promoter and
recruits RNA polymerase (RNAP) complexes that have
incorporated a second hybrid protein consisting of protein
domain Y fused to the RNAP a-subunit (Figure 2A). In this
conﬁguration,theinteractionofproteindomainsXandYleads
to an increase in reporter gene expression.
To test whether the B2H system could be used to detect
interactions between DZFs, we transformed combinations
of plasmids encoding various DZF-Zif268 DBD fusions and
Figure 2 Dimerization speciﬁcities of wild-type DZFs determined using a B2H system. (A) Schematic of B2H system used to study DZF interactions. Interaction
ofarbitrary protein domains Xand Yfusedto the Zif268 DBD andan E. coli RNAP a-subunit fragment, respectively, mediates recruitment of RNAP to aweak promoter
bearing a Zif268 binding site. RNAP recruitment leads to increased transcription of an associated reporter gene (lacZ) or co-cistronic selectable marker genes (His3
andaadA). Inthe experiments ofthisreport, domains Xand Yare DZFs.Note thattwoa-subunitsare present inanRNAP complex. (B)Pairwise combinationsof eight
wild-type DZF domains tested in the B2H system. Combinations of plasmids encoding wild-type DZFs were cotransformed into a B2H reporter strain harboring the lacZ
gene and reporter gene expression was measured by b-galactosidase assay. Each combination was tested in triplicate with mean fold-activation values and standard
errors of the means shown. Values highlighted in bold red text indicate positive interactions deﬁned as 42.5-fold activation of LacZ expression. This cutoff was chosen
basedontheobservationthatthehighestfold-activationobservedinthisassayforanoninteractingDZFpair(IkarosandTRPS-1;McCartyetal,2003)is2.5.Ik¼human
Ikaros; Eo¼human Eos; Pe¼human Pegasus; Tr¼human TRPS-1; Hd¼Drosophila melanogaster Hunchback; Hl¼Locusta migratoria Hunchback;
Hh¼Helobdella triserialis Hunchback; and Hc¼Caenorhabditis elegans Hunchback. (C) Summary of DZF interaction speciﬁcity proﬁles determined using the
B2H system. Lines indicate interactions detected among 64 pairwise combinations of eight wild-type DZFs (experiments of Figure 2B). Black lines indicate interactions
that have also been detected by other methods and red lines indicate novel interactions that have not been described previously.
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which the reporter gene is the E. coli lacZ gene encoding
b-galactosidase) and then performed b-galactosidase assays.
Using this approach, we tested all 64 possible pairwise
combinations of eight DZFs from the human Ikaros, human
Eos, human Pegasus, human TRPS-1, D. melanogaster Hunch-
back, and Hunchback homologs from grasshopper, leech, and
worms (identiﬁed using database searches; Figure 1). Our
results (Figure 2B) conﬁrm DZF interactions previously
detected by biochemical, immunoprecipitation, or yeast two-
hybrid experiments (black lines, Figure 2C). Interactions were
detected in both orientations with the exception of the TRPS-1
DZFand Eos DZF interaction, which was only detected in one
orientation. Interestingly, our experiments also reveal new
homo- and heterotypic DZF domain interactions that have not
been previously tested and/ordescribed (red lines,Figure 2C).
(We do not believe that these interactions represent false-
positives of the B2H method because they activate transcrip-
tion of the reporter gene even if their locations in the Zif268
and RNAP a-subunit hybrid proteins are reversed and because
noninteracting DZFs (e.g., from Ikaros and Drosophila Hunch-
back) fail to activate transcription of the reporter gene.) We
conclude that the B2H system can be used as a rapid and
reliable method to identify and test DZF–DZF interactions.
Construction of ‘shufﬂed’ C2H2 ZF libraries
We used two different shufﬂing approaches to construct
plasmid DNA-based libraries encoding synthetic DZFs con-
sisting of shufﬂed combinations of C2H2 ZFs (Figure 3; also
see Materials and methods). In one approach, the interﬁnger
linker remainedassociated with theamino-terminal ﬁngerand
in the other the linker remained associated with the carboxy-
terminalﬁnger.Ourlibraryconstruction strategiesdeliberately
precluded re-formation of DNA molecules encoding the
original wild-type DZFs. We created three different ‘sets’ of
shufﬂed DZF libraries, each derived from a different combi-
natorial subset of eight wild-type DZFs (details of theoretical
and actual library sizes are provided in Materials and methods
and Supplementary Table 2). As illustrated in Figure 3 (and
described in Materials and methods), each shufﬂed ‘set’
consists of four libraries: two with the synthetic DZFs
expressed as fusions to the Zif268 DBD and two expressed as
fusions to the RNAP a-subunit.
Interacting synthetic DZF pairs identiﬁed using
the B2H system
To identify interacting synthetic DZF pairs, we introduced
pairwise combinations of our various shufﬂed DZF-encoding
plasmid libraries into a ‘B2H selection strain’ harboring the
selectable, cocistronic His3 and aadA genes as reporters
(Joung et al, 2000; Hurt et al, 2003). B2H selection strain cells
expressing DZF-Zif268 and DZF-RNAP a-subunit hybrid
proteins that interact with each other should activate
transcription of the His3 and aadA genes, thereby permitting
survival and colony formation on appropriate selective media
(see details in Materials and methods). Sufﬁcient numbers of
transformed B2H selection strain cells were plated to ensure at
least 1000-fold oversampling of the theoretical number of DZF
combinations for each selection performed (see Materials and
methods and Supplementary Table 2 for additional details).
DZF-encoding plasmids were isolated from surviving colonies
and sequenced to determine the identities of C2H2 ZFs and
linkers present in the synthetic selected DZFs. We believe that
for all selections performed, we identiﬁed nearly all possible
interacting pairs as we frequently obtained multiple isolates
containing the same pair of DZFs (Table I).
As described in Materials and methods, our initial shufﬂed
library sets were constructed using DZFs from both the Ikaros
and Hunchback families (Library sets A and B). As shown in
Table I, many of the DZFs we obtained from these initial
selections were composed of C2H2 ZFs from wild-type DZFs
Figure 3 Schematic overview of shufﬂed DZF library construction and B2H
selections to identify interacting synthetic DZFs. DZFs are represented as in
Figure1.Notethatalthoughtwoa-subunitsarepresentinanRNAPcomplex,the
DZF–DZF interaction illustrated can occur presumably because either the DZF
domains on the RNAP a-fusion protein fail to dimerize (perhaps owing to a
geometrical constraint) or because the RNAP complexes that are recruited to the
promoter harbor one DZF domain a hybrid subunit and one wild-type a-subunit.
Additional details are provided inthe Results and Materials and methods section.
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Eo-Ik-Ik DZF pair at the top of Table I (see legend for
abbreviations)). However, in three of the synthetic DZF pairs
we identiﬁed (bold letters, Table I), at least one DZF in the pair
was composed of C2H2 ZFs from wild-type DZFs that do not
interact with each other (as deﬁned in the experiment of
Figure 2B above). Reasoning that synthetic DZFs from this
latter category would be more likely to possess novel
speciﬁcities, we constructed an additional shufﬂed library
(LibraryC) derived fromDZFs that, with one exception (TRPS-
1 and Eos, which interact weakly in the B2H), do not interact
with each other. Our selections with Library set C yielded only
asingleinteractingDZFpair(TableI).ThefourpairsofDZFsin
bold in Table I were chosen for further characterization. (Note
that these four pairs consist of a total of six unique DZFs
because the Pe-Pe-Eo and Eo-Eo-Hd DZFs were each identiﬁed
twice with different partners.)
Selected synthetic DZFs possess novel interaction
speciﬁcities
We examined the abilities of the synthetic DZFs we selected to
mediate protein–protein interactions using ‘B2H reporter
strains’ harboring lacZ as the reporter gene. For each of the
four DZF pairs examined, we assessed the ability of each DZF
in the pair to interact with its selected partner (heterotypic
interaction) and with itself (homotypic interaction). The
results of these assays (together with control experiments,
which demonstrate that expression of only the Zif268-DZF
fusion protein alone fails to activate lacZ expression) are
showninFigure4.Intheseexperiments,alackofreportergene
activitycan be interpreted as the absence of a productiveDZF–
DZF interaction because all DZF fusion proteins used in this
experiment are known to be stably expressed and active in the
B2H system as judged by their abilities to interact with at least
one other DZF fusion protein (Figure 4 and data not shown).
Interestingly, our results suggest that three of the four DZF
pairs we tested appear to mediate preferentially heterotypic
interactions. The preferentially heterotypic interaction speciﬁ-
cities of these three selected DZF pairs differs from all wild-
type DZFs tested to date, which possess either exclusively
homotypic or a combination of homo- and heterotypic
interaction speciﬁcities. The fourth pair consists of one DZF
(Pe-Hd-Hd) that mediates homotypic and heterotypic interac-
tions with equal efﬁciency and another DZF (Hl-Eo-Eo) that
mediatesonlyheterotypicinteraction.TheabilityofthePe-Hd-
Hdtoself-interactisnotentirelysurprisingasitsparentalDZFs
(Pegasus and Drosophila Hunchback) interact with each other
(Figure 2B).
For certain applications in synthetic biology, one may wish
to simultaneously express multiple pairs of DZFs in a single
cell. For these applications, minimal crossreactivity between
DZFs in different pairs will be critical. Ideally, each synthetic
DZF should preferentially interact with its intended partner
and not with any other synthetic DZFs expressed in the cell.
Therefore, we tested for potential crossinteractions among the
six different synthetic DZFs we selected using the B2H system.
The results of these experiments (shown in Supplementary
Table 1) demonstrate that ﬁve of the six synthetic DZFs show
excellent speciﬁcity—they interact most strongly with the
partnerDZF(s)theywereselectedtogetherwith.Onesynthetic
DZF (Pe-Hd-Hd) interacts most strongly both with the partner
DZF it was selected with (Hl-Eo-Eo) and with itself, a ﬁnding
consistent with the results of Figure 4.
Synthetic DZFs can mediate protein–protein
interactions in the nucleus of a mammalian cell
To obtain additional evidence that our synthetic DZFs mediate
speciﬁc protein–protein interactions and to test whether they
could beused tocreatesyntheticgeneregulatorynetworks, we
constructed artiﬁcial transcription factors using our DZF pairs
and tested their activities in the nucleus of human cells. To do
this, we adapted a previously described ‘activator reconstitu-
tion’ assay. In this assay (Pollock et al, 2002), an artiﬁcial,
bi-partite transcriptional activator of the endogenous human
VEGF-A gene can be created by constructing two interacting
hybrid proteins (Figure 5A): a synthetic DBD that binds to a
region of open chromatin in the human VEGF-A gene
(originally termed ‘VZþ434b’) (Liu et al, 2001) and a NF-kB
p65 transcriptional activation domain (termed ‘p65’). Thus, to
test the interaction of any given DZF pair, we fused individual
Table I Interacting pairsof synthetic shufﬂed DZF domains identiﬁed bygenetic
selection
Zif268 hybrids RNAP a hybrids Frequency
Library set A
Ik-Eo-Eo Eo-Ik-Ik 2
Ik-Eo-Eo Eo-Eo-Ik 1
Ik-Eo-Eo Ik-Eo-Eo 4
Ik-Eo-Eo Ik-Ik-Eo 1
Ik-Ik-Eo Eo-Ik-Ik 2
Ik-Ik-Eo Eo-Eo-Ik 3
Ik-Ik-Eo Ik-Ik-Eo 1
Ik-Ik-Eo Ik-Eo-Eo 1
Ik-Ik-Eo Pe-Eo-Eo 2
Ik-Ik-Eo Pe-Ik-Ik 1
Ik-Eo-Eo Pe-Eo-Eo 1
Ik-Eo-Eo Eo-Pe-Pe 1
Pe-Eo-Eo Ik-Ik-Eo 3
Pe-Pe-Hd Hd-Hd-Pe 4
Pe-Hd-Hd Hl-Eo-Eo 1
Ik-Ik-Hd Pe-Pe-Eo 1
Pe-Pe-Eo Eo-Eo-Hd 2
Ik-Ik-Hd Pe-Pe-Eo 1
Library set B
Hl-Hd-Hd Hl-Hd-Hd 2
Hd-Hl-Hl Hd-Hl-Hl 1
Pe-Hd-Hd Hl-Hd-Hd 2
Pe-Pe-Hd Hl-Hl-Hd 2
Pe-Pe-Hd Hd-Pe-Pe 4
Pe-Hd-Hd Hd-Hd-Hl 1
Pe-Pe-Hd Hd-Hd-Pe 6
Library set C
Tr-Eo-Eo Eo-Eo-Hd 3
Identities of theamino-terminalC2H2 ZF,the interﬁnger linker,and thecarboxy-
terminal C2H2 ZF (shown from left to right) for each of the synthetic DZFs
identiﬁed from the three different selection ‘sets’ A, B, and C are shown.
Abbreviationsdescribingtheparentalsourceofﬁngersandlinkersareasdeﬁned
in the legend to Figure 2. Location of the synthetic DZF on the Zif268 or RNAP
a-subunit and the number of times each pair of DZFs were isolated are shown.
Four DZF pairs chosen for additional analysis are in bold.
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activator and then tested the ability of these DZFs to mediate
transcriptional activation of the endogenous VEGF-A gene. To
do this, we transiently transfected human 293 cells, which
express low levels of VEGF-A, with plasmids that express
various DZF–DBD and DZF–p65 hybrid proteins (each
harboringanuclearlocalizationsignaltag)andthen measured
levels of VEGF-A expression by ELISA.
As expected, control experiments demonstrated that inter-
acting wild-type DZFs can mediate assembly of the bi-partite
activator, thereby stimulating VEGF-A expression (Figure 5B).
This increase is dependent on the presence of both DZF hybrid
proteins (i.e., neither hybrid alone can activate VEGF-A
expression; data not shown). In addition, no signiﬁcant
increase in VEGF-A expression is seen when noninteracting
DZFs were present in the hybrid proteins (data not shown).
Having established that DZF interactions can function to
mediate speciﬁc assembly of an artiﬁcial bi-partite activator,
we next assessed whether our four synthetic DZF pairs could
stimulate VEGF-A in the activator reconstitution assay. As
shown in Figure 5B, our results demonstrate that all four
synthetic DZF pairs can mediate efﬁcient stimulation of VEGF-
A expression in this assay. Control experiments show that the
expressionof onlytheDZF–DBD hybrid protein alone does not
activate VEGF-A expression (Figure 5B). All four pairs of our
synthetic DZFs interact in a preferentially heterotypic manner
as judged by this assay. This result contrasts with experiments
performed using the B2H reporter system (compare Figures 4
and 5B) in which only three of the four DZF pairs exhibit
preferentially heterotypic interaction speciﬁcities. We do not
know precisely why the mammalian ‘activator reconstitution’
assay does not detect self-interaction of the Pe-Hd-Hd DZF
but speculate that it may related to the observation that
homodimeric interactions (e.g., by wild-type DZFs) appear
to mediate less efﬁcient VEGF-A activation as compared with
heterodimeric interactions (e.g., by our synthetic DZFs)
(Figure 5B; also see Discussion below).
For applications in synthetic biology, it is important to
consider the possibility that certain endogenous proteins (e.g.,
other DZF-containing proteins) might also mediate competing
interactions with our synthetic DZF domains. If this were the
case, it is possible that the observed interaction speciﬁcities
of our synthetic DZF fusions might be dependent on their
overexpression relative to these other hypothetical competing
proteins. (In our VEGF-A activator reconstitution assays, our
synthetic DZF–DBD and DZF–p65 fusion proteins are likely
to be overexpressed because their expression is driven by a
strong CMV promoter and by an optimized Kozak translation
initiation sequence.) To rule out this possibility, we performed
experiments showing that (1) the interactions of synthetic
Figure 4 Homo- and heterotypic interaction speciﬁcities of synthetic DZFs assessed in the B2H system. DZFs from four pairs were tested for hetero- and homotypic
interactionusing theB2Hsystem. Controlstestingtheself-interaction ofwild-typeDZF domains(fromwhichC2H2 ZFspresent inthe syntheticDZFs werederived) were
also performed. ‘----’ indicates a plasmid encoding either the Zif268 DBD or the RNAP a-subunit with no DZF fused. Each experiment was performed at least three
times. Bars shown represent mean fold-activations of transcription in the B2H system and error bars represent standard errors of the mean. Identities of the synthetic
DZFs tested are abbreviated as in Table I.
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the speciﬁcities of DZFs are maintained even when they and
their potential interaction partners are both overexpressed.
The results of the experiments are presented in the Supple-
mentary information section and in Supplementary Figures 2
and 3.
Synthetic DZFs can mediate protein–protein
interactions in the cytoplasm of mammalian cells
Having established that our engineered DZFs can interact in
the nucleus, we next sought to determine whether they could
also interact in the cytoplasm of a human cell. To do this, we
used a previously developed co-immunoprecipitation method
to assess DZF interactions (McCarty et al, 2003). As illustrated
in Figure 6A and described in Materials and methods, a pair of
DZFs can be tested for interaction by coexpressing DZFs in
HEK293 cells as two fusion proteins of different molecular
weights: the smaller size DZF fusion harbors a FLAG tag
epitope, whereas the larger size DZF fusion does not. (Note
that in contrast to the activator reconstitution assay, none of
the DZF fusion proteins used in this experiment harbors a
nuclear localization signal.) To test for interaction, immuno-
precipitation of cytoplasmic cell lysates is performed using an
anti-FLAG antibody and then the precipitated DZF fusion
proteins are visualized using Western blotting performed with
anantibodythatrecognizesanepitopepresentinbothfusions.
As shown in Figure 6B, we found that each of our synthetic
DZF pairs mediate interaction as judged by this assay. Control
experimentsinwhich only the untagged largersize DZF fusion
is expressed demonstrate that this protein is only ‘pulled
Figure 5 Synthetic DZFs can mediate assembly of an artiﬁcial bi-partite transcription factor and activation of the endogenous VEGF-A gene in human cells.
(A) Schematic overview of a mammalian cell-based ‘activator reconstitution’ assay for testing DZF interactions. Productive interaction of DZFs (green and dark blue
ovals)fusedtoanNF-kBp65(p65) transcriptionalactivationdomain andtoasynthetic DBDthatbindsthehumanVEGF-A geneisexpectedtomediatereconstitutionof
a synthetic activator protein capable of stimulating VEGF-A expression. (B) Homo- and heterotypic interaction of synthetic DZFs assessed using the activator
reconstitution assay. Controls testing the homotypic interaction of wild-type DZF domains (from which the synthetic DZFs were derived) are shown. ‘----’ indicates a
plasmid encoding either the DBD or p65 domains with no DZF fused. DZFs tested are represented as in Table I. Fold-stimulation of VEGF-A protein expression was
calculatedusingELISAmeasurementsofsecretedVEGF-Athatwereperformedatleastthreetimes.Barsshownrepresentmeanfold-activationsofVEGF-Aexpression
and error bars indicate standard errors of the mean.
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expressed (bottom panel, Figure 6B, lanes 2, 4, and 7). We
conclude that our co-immunoprecipitation results together
with our ‘activator reconstitution’ results show that these
DZFs can function in two different compartments of a human
cell.
Interaction geometry of synthetic DZFs
Analysis of the homo- and heterotypic interaction speciﬁcities
of our synthetic DZFs suggests a potential antiparallel
interaction mode for these domains. Previous studies sug-
gested that DZFs may dimerize in a parallel mode (i.e., that
amino-terminal C2H2 ZFs in each monomer interact with each
other and carboxy-terminal C2H2 ZFs in each monomer
interact with each other) (McCarty et al, 2003). This
conclusion was based on the observation that a synthetic
Ikaros–Hunchback hybrid DZF could efﬁciently homodimer-
ize and on the assumption that the protein fragments in this
synthetic hybrid retain the interaction speciﬁcities of the DZFs
fromwhich they were derived (McCarty et al, 2003). However,
applying a similar analysis to the results of our bacterial cell-
and mammalian cell-based interaction assays (Figures 4 and
5B) suggests that the interaction mode of the four synthetic
DZF pairs we analyzed is more consistent with an antiparallel
interaction mode. For example, the Ik-Ik-Hd and Pe-Pe-Eo
DZFs interact with each other, but each interact signiﬁcantly
less efﬁciently or not at all with themselves.Assuming that the
individual C2H2 ZFs in these shufﬂed domains retain the
interaction speciﬁcities of their parental DZFs (summarized in
Figure 2C above), the observed speciﬁcities can only be
explained by an antiparallel (and not a parallel) interaction
mode.
Engineering of more extended C2H2 ZF-mediated
protein–protein interfaces
Previous studies have shown that DNA-binding C2H2 ZFs can
be linked together into tandem arrays capable of recognizing
extendedDNAsequences.Forexample,unitscomposedoftwo
C2H2 ZFs have been joined together by linkers to create four-
and six-ﬁnger proteins capable of binding 12 and 18bp DNA
sequences, respectively (Moore et al, 2001; Tan et al, 2003;
Urnov et al, 2005). We were therefore interested in testing the
hypothesis that, by analogy, extended protein–protein inter-
faces might be constructed by linking together two synthetic
DZFs to create ‘double-DZFs’ composed of four C2H2 ZFs. To
do this, we used two pairs of DZFs from our selections. These
particular pairs were chosen because both B2H reporter
system and mammalian cell ‘activator reconstitution’ experi-
mentsdemonstratedthateachDZFinthesepairsinteractsonly
withthepartneritwasselectedwithanddoesnotcrossinteract
with eitherof theDZFs inthe otherpair(depicted inFigure7A;
data in Supplementary Table 1 and Figure 1). We chose these
particular DZFs to minimize the occurrence of unwanted,
complicating inter- and intramolecular DZF–DZF interactions.
As illustrated in Figure 7B, by varying the linear order of these
DZFs, we constructed four double-DZFs: double-DZF1,
double-DZF2, double-DZF3, and double-DZF4.
To test whether double-DZFs could mediate speciﬁc inter-
actions, we used our mammalian cell-based activator recon-
stitution assay. As shown in Figure 7C, double-DZF1/double-
Figure 6 Synthetic DZFs mediate interactions in a mammalian cell-based co-immunoprecipitation assay. (A) Schematic illustrating tagged and untagged DZF fusion
proteins used in the co-immunoprecipitation assay. NTS and CTS represent amino- and carboxy-terminal portions of the Ikaros isoform I protein, respectively (see
Materials and methods for details). DZFs are represented as a pair of ovals and are present at the carboxy-terminal end of both fusion proteins. (B) Synthetic DZF
interactions analyzed using the co-immunoprecipitation assay. Cell extracts from Flp-In TRex 293 cells (Invitrogen) cotransfected with plasmids encoding combinations
of tagged and untagged DZFs or only untagged DZFs as controls (deﬁned in the key; abbreviations as inTable I) were immunoprecipitated using an anti-FLAG antibody
(seeMaterialsandmethodsfordetails).Fusionproteinsintheseextractswerevisualizedbefore(‘Input’)andafter(‘Output’)immunoprecipitationbyWesternblottingwith
an antibody that recognizes the Ikaros NTS sequence present in both types of fusion proteins. For the ‘output’ of combination #3, a longer exposure (labeled as 3* and
showntotherightoftheoutputblot)wasrequired tovisualizetheuntaggedDZF,presumablybecausetheFLAG-taggedHl-Eo-Eo DZFfusion isexpressedatalowlevel
(accounting for its absence in the Input blot where a smaller fraction of the total cellular extract is loaded relative to the Output blot).
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robust activation of VEGF-A expression greater than that
observed with the single DZF pairs from which they were
constructed. This high level of activation is similar to that
observed when the two parts of the artiﬁcial VEGF-A activator
are covalently linked together into a single molecule
(Figure 7C; Liu et al, 2001). By contrast, different pairings of
the same double-DZFs (double-DZF2/double-DZF3 and
double-DZF1/double-DZF4) stimulate VEGF-Aexpression less
efﬁciently, to a level similar to that observed with the single
DZF pairs used to construct the double-DZFs (Figure 7C). We
note that these lower levels of VEGF-A activation are not likely
to be owing to poor expression or stability of the double-DZFs
as these same proteins mediate higher levels of activation
when tested in different combinations. A simple interpretation
of these results is that double-DZF-1/double-DZF-2 and
double-DZF-3/double-DZF-4 strongly interact using both pairs
of DZFs, whereas double-DZF-2/double-DZF-3 and double-
DZF-1/double-DZF-4 interact less strongly because they
use only one of the two DZF pairs. Consistent with this
possibility, if we assume that the DZFs within the double-DZF
interact in an antiparallel manner, we would expect
the double-DZF1/double-DZF2 and double-DZF3/double-
DZF4 pairs to interact more strongly because they would be
able to use both DZFs (Figure 8, left panel). Using the
same assumption, we would also expect the double-DZF2/
double-DZF3 and double-DZF1/double-DZF4 pairs to interact
less strongly because they would be able to use only one
DZFat a time (Figure 8, left panel). By contrast, if the DZFs in
the double-DZFs interact in a parallel manner, these predic-
tions of relative afﬁnity would be reversed (Figure 8, right
panel). Thus, the pattern of relative interaction strengths
observed with double-DZFs in the activator reconstitution
assay provides additional compelling evidence for the anti-
parallel interaction of the synthetic DZFs we selected in this
study.
Figure 7 Synthetic double-DZFs interact in mammalian cells. (A) Interaction speciﬁcities of synthetic DZFs used to construct double-DZFs. Interaction speciﬁcities
shown (arrows) were determined using the B2H system and the mammalian cell-based ‘activator reconstitution’ assay as reporters (Supplementary Table 1 and Figure
1). Red X’s indicate no signiﬁcant interaction was detectable in either system. (B) Schematic of synthetic double-DZFs. Inter-DZF linkers are shown as black lines and
are described in Materials and methods. (C) Interaction of double-DZF pairs assessed using the mammalian cell-based activator reconstitution assay. Controls testing
the interaction of single DZF pairs and of an intact synthetic VEGF-A activator (consisting of the DBD that binds the VEGF-A gene covalently fused to the NF-kB p65
activationdomain)arealso shown.Fold-stimulation ofVEGF-A proteinexpression wascalculatedusing ELISAmeasurements of secretedVEGF-Athatwere performed
at least three times. Bars shown represent mean fold-activations of VEGF-A expression and error bars indicate standard errors of the mean.
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Shufﬂing of DZF-derived C2H2 ZFs yields novel
protein–protein interactions
Before this study, it was not known whether protein-
interacting C2H2 ZFs, like their DNA-binding counterparts,
could be mixed and matched to create synthetic proteins with
novel binding speciﬁcities. Intrigued by a previous report that
described a functional chimeric DZF (McCarty et al, 2003) and
by the sequencevariation and functional diversityof wild-type
DZFs, we systematically investigated whether C2H2 ZFs and
DZFs could be ‘mixed and matched’ to create domains with
novel interaction speciﬁcities. Our results show that shufﬂing
of DZF-derived C2H2 ZFs can yield synthetic DZFs with new
speciﬁcities that can in turn be linked together to create more
extendedinteractioninterfaces.(WepresumethattheDZFswe
have created interact as dimers, although we cannot rule out
that they may interact as higher-order oligomers because
recent studies suggest that the Eos DZF may self-interact as a
multimer of as many as 10 molecules (Westman et al, 2003).)
The ability to create domain-shufﬂed DZFs is consistent with
recent biophysical studies showing that C2H2 ZFs in the Eos
DZF fold independently of each other (Westman et al, 2004).
Although our results clearly demonstrate that certain DZF-
derived C2H2 ZFs can be shufﬂed, we note that only a small
number (26 pairs; Table I) of the potential combinations of
DZFs produced by our shufﬂing strategies (5344 combina-
tions; Supplementary Table 2) actually were identiﬁed by our
selections. We believe that our experiments identiﬁed nearly
all interacting pairs of synthetic DZFs in our libraries because
we vastly oversampled the theoretical number of combina-
tions in our selections and because our sequencing results
revealed that we identiﬁed many of the interacting pairs
multiple times. The fact that less than 0.5% (26 selected DZF
pairs/5344 total potential pairs) of the potential interacting
DZF pairs were positive for interaction emphasizes the
importance of the B2H selection method for the success of
our experiments. This low frequency also explains why initial
attemptsbyourgroupto create synthetic DZFs without theuse
of the B2H selection method were unsuccessful (A Giesecke
and JK Joung, unpublished data). Although it is possible that
at least some of the synthetic DZFs encoded in our libraries are
poorlyexpressed,unfolded, unstable, ortoxic,wehypothesize
that the small number of interacting DZF pairs identiﬁed may
bea consequence ofthe fact that DZF-derivedC2H2ZFs do not
always behave in a fully modular manner. DNA-binding C2H2
ZFs exhibit context-dependent effects (Wolfe et al, 1999, 2001;
Hurt et al, 2003) and it is therefore not surprising that protein-
interacting ﬁngers might also be subject to such effects.
Important future studies will include obtaining detailed
thermodynamic and kinetic information regarding DZF inter-
Figure 8 Antiparallel and parallel interaction models for synthetic double-DZFs. Interaction models illustrated assume that the individual DZFs interact only with the
partner DZF with which they were selected (as in Figure 7A). Identities of double-DZFs and the single DZFs from which they were constructed are color-coded as in
Figure 7. Note that in certain cases more than one potential interaction mode is predicted.
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be challenging owing to technical barriers (e.g., insolubility,
aggregation) that have thwarted efforts to purify intact,
untagged DZFs (A Giesecke, R Fang, and JK Joung, unpub-
lished data). We have encountered these issues with both
wild-type and synthetic DZF domains and other laboratories
have also reported encountering technical difﬁculties in
isolating intact DZFs for biochemical and structural studies
(McCarty et al, 2003; Westman et al, 2003, 2004). However,
despite this limitation, we can estimate an approximate upper
boundary for dissociation constants of DZF–DZF interactions
based on the observation that transcriptional activation in the
B2H has been observed with dissociation constants as high as
B1mM (Dove et al, 1997). Although previous studies have
suggested that the magnitude of transcriptional activation
observed in the B2H system correlates with the strength of the
interaction (Dove et al, 1997), we hesitate to apply such a
correlation to DZF–DZF interactions owing to potentially
confounding effects of self-interaction by each of the DZF
hybrid proteins.
An alternative ‘antiparallel’ interaction mode
for DZFs
Our selection experiments revealed a potential antiparallel
interaction mode for DZF domains.Previous studies suggested
that DZFs might dimerize in a parallel mode with the amino-
terminal C2H2 ZFs in each monomer interacting with each
other and the carboxy-terminal C2H2 ZFs in each monomer
interacting with each other (McCarty et al, 2003). Two
observations suggest that our synthetic DZFs interact in an
alternative antiparallel geometry. First, as noted above, the
identities of C2H2 ZFs and the homo- and heterotypic
speciﬁcities of our synthetic DZFs (determined in bacterial
cell- and mammalian cell-based interaction assays; Figures 4
and 5B) strongly suggests that these DZFs interact in an
antiparallel manner. Second, the interaction speciﬁcities of the
four-ﬁnger double-DZFs we constructed are most consistent
with a model inwhich the component DZFs interact in an anti-
parallel manner (Figures 7 and 8).
We note that our ﬁndings do not preclude the existence
of a previously proposed parallel DZF–DZF interaction
mode (McCarty et al, 2003). In fact, inspection of the
sequences of our selected DZF pairs identiﬁes at least one
synthetic DZF pair whose C2H2 ZF composition suggests a
parallel interaction mode (Pe-Hd-Hd and Hd-Hd-Hl; Table I).
The ﬁnding of both parallel and antiparallel interaction
geometries for DZFs is reminiscent of the behavior of leucine
zippers, which can mediate homo- and heterotypic interac-
tions among eukaryotic transcription factors and can interact
as parallel or antiparallel coiled-coils (Light et al, 1996;
Walshaw and Woolfson, 2001; Vinson et al, 2002). The
existence of two potential interaction modes for synthetic
DZFs raises the important question of which orientation(s)
is utilized by naturally occurring DZFs. Future biophysical
and structural studies (once puriﬁed DZF domains can be
obtained) should provideimportant insights into thephysical–
chemical parameters that dictate the geometric orientation of
DZF–DZF interactions.
Applications of artiﬁcial protein-interacting C2H2
ZF domains to synthetic biology
We have demonstrated that our synthetic interacting DZF pairs
can potentially be useful for applications in synthetic biology.
First, we have shown that our synthetic DZFs can be used to
construct synthetic, bi-partite transcriptional activators cap-
able of stimulating expression of the endogenous VEGF-A gene
inhumancellsevenintheabsenceofnormalregulatorysignals
such as hypoxia. This represents an example of synthetic
control as we have by-passed the normal regulatory mechan-
isms of the VEGF-A gene. Furthermore, because this activation
depends upon the presence of two DZF-containing proteins, it
provides a mechanism for making VEGF-A expression code-
pendent on two inputs (e.g., as in an ‘AND’ circuit). Our results
are particularlyrelevantbecauseanimportantgoalofsynthetic
biology is the creation of artiﬁcial proteins and networks that
interfacewith,andinﬂuencethebehaviorof,endogenousgene
expressionpatterns.Second,wehavealsoshownthatsynthetic
DZF domains (together with DNA-binding C2H2 ZFs) can be
used to activate expression of a speciﬁc gene in a bacterial cell.
Thus, artiﬁcial DNA-binding C2H2 ZFs and DZFs provide the
synthetic biologist with potential parts for creating multiple
transcriptional activators, a capability useful for constructing
synthetic circuits in bacteria.
Because our synthetic DZF domains mediate preferentially
heterotypic interactions, they provide important additional
functionality compared with naturally occurring wild-type
DZFs, which mediate preferentially homotypic or mixed
homo- and heterotypic interactions (Figure 2C). Heterotypic
interactions may be particularly useful for applications
requiring asymmetric complex assembly. For example, our
experiments suggest that most of our synthetic preferentially
heterotypic DZFs are more efﬁcient at mediating assembly of
a bi-partite transcription factor in our mammalian cell-based
‘activator reconstitution’ assay than naturally occurring
homotypic DZFs (Figure 5B). One possible reason for this
difference may be the formation of undesired homodimers of
DBD fusions or activation domain fusions mediated by the
wild-type homotypic DZFs that compete with the formation of
the desired DBD/activation domain heterodimer.
An important goal for future studies will be to obtain more
synthetic C2H2 ZF domains with novel speciﬁcities using the
ﬁnger shufﬂing and selection approaches described in this
report. Additional sources of C2H2 ZFs for future shufﬂed
libraries include other naturally occurring DZFs or protein-
interacting domains. Alternatively, by analogy with engineer-
ing work carried out with DNA-binding C2H2 ZFs and with
leucine zipper interaction domains, it may be possible to
randomize residues within DZF-derivedﬁngers that have been
shown to be important for mediating protein–protein interac-
tions(McCartyetal,2003;Westmanetal,2004)tocreateC2H2
ZFs with completely novel speciﬁcities. Additional mutagen-
esis and high-resolution structures of DZFs will help further
reﬁne the choice of residues for randomization. Shufﬂing of
these various naturally occurring and re-engineered C2H2 ZFs
combined with selections in the B2H could yield ﬁnger arrays
with novel interaction speciﬁcities different from the domains
already obtained in this report. We note that our studies
indicate that theB2H systemfunctions asaneffectiveselection
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mammalian cell context.
Another interesting issue for future experiments will be to
examine to what degree, if any, our synthetic DZFs interact
with endogenous proteins in different cellular contexts. Our
data show that synthetic DZFs function in the cytoplasm of
bacterial cells and in the nucleus and cytoplasm of human
cells.These results demonstratethat anypotential interactions
with the hundreds, if not thousands, of endogenous proteins
expressed in these two cellular contexts (including C2H2 ZF
and DZF proteins) do not interfere with the abilities of our
synthetic DZF pairs to interact, even when the expressionlevel
of our domains is lowered by seven-fold or more. Given that
little is known about protein–protein interactions mediated by
C2H2ZFsandgiventhelargenumbersofC2H2ZFsencodedin
eukaryotic cells (43000 domains in the human genome
alone), a challenge for future studies will be to develop
methods for identifying all possible protein interaction
partners of our synthetic DZFs.
The demonstration that DZFs can be joined together into
more extended arrays (to create double-DZFs) also expands
the utility of our synthetic protein-interacting domains. Our
results suggest that interfaces of variable afﬁnities can be
produced by varying the number of ﬁngers present at the
interface. In addition, we speculate that it may be possible to
engineer synthetic, multi-DZF ‘scaffolds’ or ‘adaptors’ upon
which various DZF-linked proteins might be assembled.
Successful creation of such scaffolds could permit the creation
of ‘circuit components’ in which various cellular pathway
inputs (e.g., kinases, transcription factors) might be integrated
into a single output (Park et al, 2003). The capability to
engineer synthetic C2H2 ZFs with novel protein–protein
interaction speciﬁcities, particularly when coupled with
existing technologies for constructing designer C2H2 ZF
DNA-binding proteins, should expand the range of potential
‘parts’ available to synthetic biologists for constructing
artiﬁcial cellular networks.
Materials and methods
B2H plasmids and strains
DNA fragments encoding DZF domains were either ampliﬁed from a
human cDNA library (Panomics) using polymerase chain reaction or
assembled using synthetic overlapping oligonucleotides. Each DZF-
encoding DNA fragment was cloned into plasmid pACYC-a (for
expression as a carboxy-terminal fusion with the amino-terminal
domain and intersubunit linker of the E. coli RNAP a subunit) and
plasmid pBR-UV5-Zif268 (for expression as an amino-terminal fusion
with the Zif268 DBD). Plasmid pACYC-a encodes the amino-terminal
domain and linker (residues 1–248) of the E. coli RNA polymerase a
subunit expressed from an isopropyl b-D-thiogalactosidase (IPTG)-
inducible lpp/lacUV5 tandem promoter. Plasmid pBR-UV5-Zif268
encodes the DNA-binding C2H2 ZF domain of the murine Zif268
protein (residues 327–421) expressed from the IPTG-inducible lacUV5
promoter (Joung et al, 2000).
Strains used for B2H experiments were derived from strain KJ1C
(Joung et al, 2000) and harbor a recombinant F0 (constructed as
previouslydescribed (Hurt et al, 2003)) bearingthe Zif268 binding site
centered at position  65 relative to the transcription start point of a
modiﬁed lac promoter directing expression of either the lacZ gene (in
the ‘B2H reporter strain’) or the cocistronic His3 and aadA genes (in
the ‘B2H selection strain’). The F0 reporter is strictly maintained at
single copy in E. coli strains.
b-Galactosidase reporter assays
b-Galactosidase assays were performed in triplicate as described
previously(Thibodeauetal,2004).Brieﬂy,thismethodinvolveslysing
logarithmic phase bacterial cultures grown in LB (containing 50mg/ml
carbenicillin, 30mg/ml chloramphenicol, 30mg/ml kanamycin,
10 mM ZnCl2 or ZnSO4, and 50mM IPTG) using a commercially
available lysis reagent (BugBuster, Novagen) and then assaying these
extracts for b-galactosidase activity by monitoring the ability of this
enzyme to process a substrate (ONPG) that yields a yellow color
upon cleavage.
Construction of shufﬂed DZF domain libraries
For each library we constructed, two strategies were used to create
shufﬂed combinations of DZF-derived C2H2 ZFs: one in which the
interﬁnger linker remained associated with the amino-terminal C2H2
ZF and another in which the linker remained associated with the
carboxy-terminal C2H2 ZF (Figure 3). These two different types of
combinatorial pools were constructed by performing directional
ligation of DNA fragments in a way that speciﬁcally precluded the
formation of DNAs encoding wild-type DZFs. (Additional details of
library construction are available upon request.) Each of these two
different shufﬂed pools was then ligated into the compatible pACYC-a
and pBR-UV5-Zif268 plasmids so that these domains could be
expressed as fusions to the E. coli RNAP a-subunit and the Zif268
DBD, respectively (Figure 3). This approach yields a ‘set’ of four
different plasmid libraries that can be used for selections in the B2H
system (Figure 3): two libraries expressed as E. coli RNAP a-subunit
hybrid proteins and two libraries expressed as Zif268 DBD hybrid
proteins.
Different ‘sets’ of libraries were constructed by shufﬂing combina-
tions of C2H2 ZFs derived from various subsets of eight wild-type
DZFs: set A consisted of shufﬂed combinations of the human Ikaros,
human Eos, human Pegasus, D. melanogaster Hunchback, Locusta
migratoria Hunchback, and Helobdella triserialis Hunchback DZFs;
set B consisted of shufﬂed combinations of the human Pegasus,
D. melanogaster Hunchback, and L. migratoria Hunchback DZFs; and
setC consisted of shufﬂedcombinations of human Eos, human TRPS-1,
D. melanogaster Hunchback, H. triserialis Hunchback, and Caenor-
habditis elegans Hunchback. Statistics describing the theoretical and
actual number of candidates in each of the four libraries of each ‘set’
are provided in the ﬁrst two columns of Supplementary Table 2. Note
that the actual number of candidates in each library we constructed
exceeded the theoretical number of potential combinations by at least
500-fold, ensuring that nearly all possible shufﬂed DZFs should be
present in each of our libraries.
B2H selections
Three independent ‘groups’ of selection experiments were performed,
each using one of the three library ‘sets’ (A, B, and C). For each
selection ‘group,’ four different selections testing all possible pairwise
combinations of the four libraries in a ‘set’ were tested for potential
interactions. The theoretical numbers of combinations for each
selection in each set are shown in column 3 of Supplementary Table
2. Thus, the total number of combinations interrogated by all three
‘groups’ of selections is 5344¼(900 DZF combinations 4
selections)þ(36 DZF combinations 4 selections)þ(400 DZF
combinations 4 selections). Pairs of libraries were introduced
serially into ‘B2H selection strain’ cells with the RNAP a-fusion library
introduced ﬁrst by electroporation followed by the Zif268 fusion
library introduced by phagemid infection as described previously
(Joungetal,2000).Notethatforeachselectionperformed,thenumber
of transformants plated (typically B10
6–10
7) exceeded the theoretical
number of potential combinations by at least 1000-fold (see column
4 of Supplementary Table 2), thereby ensuring that essentially all
possibleDZF–DZFcombinationsweretestedfor interaction. Increased
His3 expression in DhisB KJ1C cells permits growth on histidine-
deﬁcient mediumand increased aadA gene expression permitsgrowth
on medium containing streptomycin (Joung et al, 2000). Thus,
transformed cells were platedon histidine-deﬁcient NM medium(Hurt
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petitive inhibitor of HIS3), and 40mg/ml streptomycin. Following 2 days
of growth at 371C, four to 12 surviving colonies were picked from each
selection for linkage analysis.
Linkage analysis was performed by isolating plasmid DNA from
candidates that survived the selection, purifying each of the two
plasmids independently, and then introducing pairs of puriﬁed
plasmids into ‘B2H reporter strains’ and performing b-galactosidase
assays. Plasmid pairs that result in elevated level of b-galactosidase
expression were then sequenced to determine the identities of the
C2H2 ZFs and linkers.
Mammalian cell-based ‘activator reconstitution’
assay
We constructed mammalian expression plasmids that encode hybrid
proteins consisting of one or two DZF domains joined to the carboxy-
terminus of the human NF-kB p65 subunit (residues 283–551) by a
short Gly-Ser linker. A similar series of plasmids were constructed to
express fusion proteins consisting of one or two DZF domains joined
by a short linker of sequence GPGS to the carboxy-terminus of an
engineered C2H2 ZF DBD that binds to the human VEGF-A gene (the
VZþ434b domain from Liu et al (2001)). In all of these plasmids,
expression of the fusion protein is driven bya modiﬁed CMV promoter
thatcanberepressedbytetracyclinerepressor(fromplasmidpcDNA5;
Invitrogen) and all fusions harbor a nuclear localization signal from
thesimianvirus40(SV40)largeTantigenattheiramino-terminus.The
DZFs in double-DZF1, double-DZF2, and double-DZF4 were joined by
a linker of sequence GEKP, whereas the DZFs in double-DZF3 were
joined by a linker of sequence EFPKPSTPPGSSGGAP.
Flp-In TRex 293 cells (Invitrogen) expressing tetracycline repressor
were grown in Dulbecco’s modiﬁed Eagle’s medium supplemented
with 10% fetal bovine serum in a 5% CO2 incubator at 371C. To
perform transient transfections, cells were plated in 24-well plates
(Corning) at a density of 150000 cells/well 24h before transfection.
Plasmids encoding DZF–DBD and DZF–p65 fusions were transfected
into cells using 1ml of Lipofectamine (Invitrogen) and 0.5mg total
plasmid DNA per well. At B16h following transfection, medium was
removed and replaced with fresh medium containing doxycycline
(1mg/ml) to induce the expression of the fusion proteins. At 24h after
induction, the culture medium was harvested and secreted VEGF-A
levels in the culture medium quantiﬁed using ELISA (R&D Systems)
performed according to the manufacturer’s protocol, except that
values were normalized to the number of viable cells (determined
using WST-1 reagent; Roche).
Western blot analysis
FLAG-tagged DZF hybrid proteins were created by inserting an amino-
terminal FLAG tag-coding sequence into the DZF–DBD and DZF–p65
fusion plasmids. The DZF–DBD and DZF–p65 constructs were
cotransfected into HEK293 cells (seeded in 24-well plates) using
Lipofectaminewith0.25mgoftheDZF–DBDplasmidandeither0.25or
0.06mg of the DZF–p65 fusion plasmid (0.19mg of pcDNA5 plasmid
DNAwasusedtokeepthetotalDNAamountofDNAaddedconstantat
0.5mg). The medium was removed and replaced with fresh medium
containing doxycycline (1mg/ml)B16h after transfection. At 24h after
induction, the culture medium and the cells were harvested. Secreted
VEGF-A levels in the culture medium were quantiﬁed using ELISA
(R&D Systems).
ForWesternblotanalysisoftheDZFhybridproteinexpressionlevel,
cells were lysed using Laemmli sample loading buffer. The amounts of
lysate loaded on each SDS–polyacrylamide gel electrophoresis (PAGE)
gel were normalized using the number of viable cells in each
transfection (determined using WST-1 reagent; Roche). Western blot
analysis was performed using the anti-FLAG M2 monoclonal antibody
(Sigma). Anti-mouse IgG (Amersham Biosciences) served as a
secondary antibody and ECL (Amersham Biosciences) was used for
visualization. Band intensities were quantiﬁed using a Biorad Fluor-S
MultiImager and Quantity One software.
Mammalian cell-based co-immunoprecipitation
assay
DZFs were expressed as one of two different fusion proteins, one
untagged and one tagged with a FLAG epitope. These proteins
(illustrated schematically in Figure 6A) contain various portions of
the murine Ikaros protein as described previously (McCarty et al,
2003). None of the DZF fusion proteins made for these experiments
harbored a nuclear localization signal. Sequences encoding these
proteinswereclonedintoplasmidpcDNA3(Invitrogen)suchthattheir
expression is directed by the constitutive CMV promoter.
Co-immunoprecipitation assays were performed essentially as
describedpreviously(Cupitetal,2003;McCartyetal,2003).Conﬂuent
Flp-In TRex 293 cells were transfected with pairs of plasmid DNAs
(10mg total) using the calcium phosphate method. Cells were
harvested 48h after transfection and resuspended in cold buffer A
(10mM HEPES (pH 7.8), 1.5mM MgCl2, 10mM KCl, 20mM ZnCl2,
1mM DTT, 1mM benzamidine, one tablet of protease inhibitor per
5ml). Cells were homogenized and cytoplasmic extracts were clariﬁed
before use by microcentrifugation. 200ml of cold RIPA buffer (150mM
NaCl, 50mM Tris (pH 7.5), 0.1% SDS, 1% NP40, 0.025% sodium
deoxylate, 1mM DTT) was added to 10ml lysate. RIPA buffer-
equilibrated Anti-FLAG M2 Afﬁnity Gel (Sigma) was then added and
the sample was rotated for 1.5h and 41C. The beads were collected by
centrifugation, washed three times with 1ml of cold RIPA buffer,
mixed with 30ml2 SDS sample buffer, boiled, and centrifuged. The
resulting supernatants were resolved by SDS–PAGE. Western blot
analysis was performed using the Ikaros M-20 antibody (Santa Cruz
Biotechnology) directed against the amino-terminal 53 amino acids of
Ikaros. Monoclonal anti-goat IgG (Sigma) was used as secondary
antibody and ECL (Amersham) was used for visualization.
Supplementary information
Supplementary information is available at Molecular Systems Biology
website (www.nature.com/msb).
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